Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report

by Wolfgang Füreder, Peter Valent
Published 2020-08-01

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?

by Lisa Pleyer, Peter Valent, Richard Greil
Published 2016-06-01

A Joint Sedimentation-Flood Retention Assessment of a Small Water Reservoir in Slovakia: A New Hope for Old Reservoirs?

by Peter Valent, Roman Výleta, Michaela Danáčová
Published 2019-04-01

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms

by Gregor Hoermann, Georg Greiner, Peter Valent
Published 2015-01-01

Mastocytosis, MCAS, and Related Disorders—Diagnosis, Classification, and Therapy

by Marek Niedoszytko, Peter Valent, Bogusław Nedoszytko
Published 2021-05-01

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology

by Gregor Hoermann, Georg Greiner, Andrea Griesmacher, Peter Valent
Published 2020-08-01

Searching for Pareto Fronts for Forest Stand Wind Stability by Incorporating Timber and Biodiversity Values

by Ján Merganič, Katarína Merganičová, Jozef Výbošťok, Peter Valent, Ján Bahýľ, Rasoul Yousefpour
Published 2020-05-01

Estimation of the impact of climate change-induced extreme precipitation events on floods

by Kamila HLAVČOVÁ, Milan LAPIN, Peter VALENT, Ján SZOLGAY, Silvia KOHNOVÁ, Peter RONČÁK
Published 2015-09-01

Impact of Climate and Geology on Event Runoff Characteristics at the Regional Scale

by Xiaofei Chen, Juraj Parajka, Borbála Széles, Peter Valent, Alberto Viglione, Günter Blöschl
Published 2020-12-01

E- and p-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft model.

by Daniel Wicklein, Anna Schmidt, Vera Labitzky, Sebastian Ullrich, Peter Valent, Udo Schumacher
Published 2013-01-01

Therapeutic Vulnerabilities in <i>FLT3</i>-Mutant AML Unmasked by Palbociclib

by Iris Z. Uras, Barbara Maurer, Sofie Nebenfuehr, Markus Zojer, Peter Valent, Veronika Sexl
Published 2018-12-01

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis

by Knut Brockow, Katarzyna Plata-Nazar, Magdalena Lange, Bogusław Nedoszytko, Marek Niedoszytko, Peter Valent
Published 2021-03-01

Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines In Vitro and Inhibits Melanoma Growth in Xenograft Mouse Model

by Rainer Hubmann, Wolfgang Sieghart, Susanne Schnabl, Mohammad Araghi, Martin Hilgarth, Marlies Reiter, Dita Demirtas, Peter Valent, Peter Valent, Christoph Zielinski, Christoph Zielinski, Ulrich Jäger, Ulrich Jäger, Medhat Shehata, Medhat Shehata
Published 2017-07-01

High Precision Individual Tree Diameter and Perimeter Estimation from Close-Range Photogrammetry

by Martin Mokroš, Jozef Výbošťok, Julián Tomaštík, Alžbeta Grznárová, Peter Valent, Martin Slavík, Ján Merganič
Published 2018-11-01

Process-based selection of copula types for flood peak-volume relationships in Northwest Austria: a case study

by Silvia KOHNOVÁ, Ladislav GAÁL, Tomáš BACIGÁL, Ján SZOLGAY, Kamila HLAVČOVÁ, Peter VALENT, Juraj PARAJKA, Günter BLÖSCHL
Published 2016-12-01

The transcription factor MAZR preferentially acts as a transcriptional repressor in mast cells and plays a minor role in the regulation of effector functions in response to FcεRI s...

by Anastasia Abramova, Shinya Sakaguchi, Alexandra Schebesta, Hammad Hassan, Nicole Boucheron, Peter Valent, Axel Roers, Wilfried Ellmeier
Published 2013-01-01

Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches

by Peter Valent, Cem Akin, Karoline V. Gleixner, Wolfgang R. Sperr, Andreas Reiter, Michel Arock, Massimo Triggiani
Published 2019-06-01

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis

by Edyta Reszka, Ewa Jabłońska, Edyta Wieczorek, Peter Valent, Michel Arock, Gunnar Nilsson, Bogusław Nedoszytko, Marek Niedoszytko
Published 2021-03-01

Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond

by Bettina Sprinzl, Georg Greiner, Goekhan Uyanik, Michel Arock, Torsten Haferlach, Wolfgang R. Sperr, Peter Valent, Gregor Hoermann
Published 2021-02-01

Nilotinib and imatinib are comparably effective in reducing growth of human eosinophil leukemia cells in a newly established xenograft model.

by Daniel Wicklein, Nuno Ramos Leal, Johannes Salamon, Mohammed Thamer, Harald Herrmann, Peter Valent, Udo Schumacher, Sebastian Ullrich
Published 2012-01-01